Fluocinolone acetonide intravitreal implants in vogt-koyanagi-harada disease

Yousuf Khalifa, Allison R. Loh, Nisha R. Acharya

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Purpose: To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH). Design: Interventional case series. Methods: Retrospective review of medical records. Results: Two patients with VKH requiring high-dose systemic corticosteroid therapy to control their inflammation and bilateral serous retinal detachments received bilateral fluocinolone acetonide implants. Upon tapering of systemic corticosteroids, one patient had recurrent serous retinal detachments and the other patient's anterior chamber and vitreous inflammation returned. Conclusions: The authors' experience with fluocinolone acetonide implants in VKH has been mixed with an inability to fully taper off of systemic corticosteroids.

Original languageEnglish (US)
Pages (from-to)431-433
Number of pages3
JournalOcular Immunology and Inflammation
Issue number6
StatePublished - Dec 2009
Externally publishedYes


  • Fluocinolone acetonide intravitreal implant
  • Uveitis
  • Vogt-Koyanagi-Harada

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology


Dive into the research topics of 'Fluocinolone acetonide intravitreal implants in vogt-koyanagi-harada disease'. Together they form a unique fingerprint.

Cite this